Gisbert, J P <br/><br/>
First-line triple therapy with levofloxacin for Helicobacter pylori eradication.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Aug 2007 
 - 495-500 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2007.03384.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amoxicillin--administration & dosage<br/>Anti-Bacterial Agents--administration & dosage<br/>Anti-Ulcer Agents--administration & dosage<br/>Bismuth--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori<br/>Humans<br/>Levofloxacin<br/>Male<br/>Middle Aged<br/>Ofloxacin--administration & dosage<br/>Prospective Studies<br/>Ranitidine--administration & dosage<br/>Treatment Outcome